NYSE:MDTMedical Equipment
Medtronic’s SPR Therapeutics Deal Broadens Chronic Pain Neuromodulation Story
Medtronic (NYSE:MDT) has announced an agreement to acquire SPR Therapeutics.
The deal brings SPR’s FDA cleared SPRINT PNS System into Medtronic’s chronic pain management portfolio.
The transaction is aimed at expanding Medtronic’s Neuromodulation business with temporary peripheral nerve stimulation technology.
For you as an investor, this move remains within Medtronic’s core line of business in medical devices for chronic conditions, including pain. Chronic pain is a large treatment area...